MNDA and RBL2

Number of citations of the paper that reports this interaction (PubMedID 16458891)
9

Data Source:
HPRD (in vitro)

		MNDA	RBL2
Description		myeloid cell nuclear differentiation antigen	RB transcriptional corepressor like 2
Image
GO Annotations	Cellular Component	Extracellular Region Nucleoplasm Nucleolus Azurophil Granule Lumen Extracellular Exosome Ficolin-1-rich Granule Lumen	Chromatin Nucleoplasm Transcription Factor Complex Nucleolus Cytosol Extracellular Exosome
	Molecular Function	Double-stranded DNA Binding Protein Binding	RNA Polymerase II Regulatory Region DNA Binding RNA Polymerase II Activating Transcription Factor Binding Protein Binding Promoter-specific Chromatin Binding
	Biological Process	Activation Of Innate Immune Response Cellular Defense Response Cellular Response To DNA Damage Stimulus Negative Regulation Of B Cell Proliferation Positive Regulation Of Interleukin-1 Beta Production Cellular Response To Interferon-beta Positive Regulation Of Apoptotic Process Neutrophil Degranulation B Cell Receptor Signaling Pathway	Chromatin Organization Regulation Of Transcription By RNA Polymerase II DNA Damage Response, Signal Transduction By P53 Class Mediator Resulting In Cell Cycle Arrest Regulation Of Mitotic Cell Cycle Negative Regulation Of Gene Expression Cell Differentiation Regulation Of Lipid Kinase Activity Regulation Of Cell Division Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle
Pathways		Neutrophil degranulation	Transcription of E2F targets under negative control by DREAM complex Transcription of E2F targets under negative control by DREAM complex Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 G0 and Early G1 TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest Cyclin E associated events during G1/S transition G1/S-Specific Transcription G1/S-Specific Transcription Cyclin D associated events in G1 Cyclin A:Cdk2-associated events at S phase entry FOXO-mediated transcription of cell cycle genes
Drugs
Diseases
GWAS		Metabolite levels ( 23823483) Obesity-related traits ( 23251661) Perceived intensity of aspartame ( 31005972)	Body fat mass ( 28552196) General cognitive ability ( 29844566) Height ( 28552196) Intelligence (MTAG) ( 29326435) Metabolite levels ( 23823483)
Interacting Genes		13 interacting genes: CDK1 CDK2 CRK FBXO7 HOXB2 MAPK8IP2 NSD3 PRMT6 PRMT7 RB1 RBL2 STAT3 TP53	44 interacting genes: BRCA1 BRF1 BRF2 CCNA1 CCNA2 CCND1 CCND3 CCNE1 CDK2 CDK4 CDK6 CREG1 DCTN1 DGKZ E2F4 E2F5 EZH2 GRAMD4 HBP1 HDAC1 ID2 KMT5C LBX1 LDHC LIN52 MCM7 MNDA PCBD1 PHB PPP2CA RAF1 RBBP8 RBBP9 RINT1 SKP2 SMARCA4 SNW1 SUV39H1 TAF1 TOP1 TP53BP1 UBTF USP4 XBP1
Entrez ID		4332	5934
HPRD ID		15932	01576
Ensembl ID		ENSG00000163563	ENSG00000103479
Uniprot IDs		P41218 Q5VUU6	Q08999
PDB IDs		2DBG 5H7Q 5WPZ	4XI9 5C1D
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?